文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Tianhuang formula reduces the oxidative stress response of NAFLD by regulating the gut microbiome in mice.

作者信息

Luo Duosheng, Yang Ling, Pang Huiting, Zhao Yating, Li Kunping, Rong Xianglu, Guo Jiao

机构信息

Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangzhou, China.

Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou, China.

出版信息

Front Microbiol. 2022 Sep 21;13:984019. doi: 10.3389/fmicb.2022.984019. eCollection 2022.


DOI:10.3389/fmicb.2022.984019
PMID:36212891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9533869/
Abstract

BACKGROUND: The gut microbiome affects the occurrence and development of NAFLD, but its mechanism has not yet been fully elucidated. Chinese medicine is a new treatment strategy to improve NAFLD by regulating the gut microbiome. Tianhuang formula (TH) has been proved to have a lipid-lowering effect in which constituents of ginsenoside Rb1, ginsenoside Rg1, ginsenoside Rb, ginsenoside Re, and ginsenoside R1 from and berberine, palmatine, and coptisine from have low drug permeability, which results in poor intestinal absorption into the human body, and are thus able to come into contact with the gut microflora for a longer time. Therefore, it might be able to influence the gut microbial ecosystem, but it still needs to be investigated. METHOD: The characteristics of the gut microbiome were represented by 16S rRNA sequencing, and the metabolites in intestinal contents and liver were discovered by non-targeted metabolomics. Correlation analysis and fermentation experiments revealed the relationship between the gut microbiome and metabolites. Blood biochemical indicators, liver function indicators, and oxidation-related indicators were assayed. H&E staining and Oil Red O staining were used to analyze the characteristics of hepatic steatosis. RT-qPCR and western blotting were used to detect the expression of genes and proteins in liver tissues, and fecal microbial transplantation (FMT) was performed to verify the role of the gut microbiome. RESULTS: Gut microbiome especially reduced, metabolites such as 5-Methoxyindoleacetate (5-MIAA) significantly reduced in the liver and intestinal contents, the level of hepatic GSH and SOD reduced, MDA increased, and the protein expression of Nrf2 also reduced in NAFLD mice induced by high-fat diet (HFD). The normal diet mice transplanted with NAFLD mice feces showed oxidative liver injury, indicating that the NAFLD was closely related to the gut microbiome. TH and TH-treated mice feces both can reshape the gut microbiome, increase the abundance of and the content of 5-MIAA in intestinal contents and liver, and improve oxidative liver injury. This indicated that the effect of TH improving NAFLD was related to the gut microbiome, especially . 5-MIAA, produced by , was proved with fermentation experiments . Further experiments proved that 5-MIAA activated the Nrf2 pathway to improve oxidative stress in NAFLD mice induced by HFD. TH reshaped the gut microbiome, increased the abundance of and its metabolite 5-MIAA to alleviate oxidative stress, and improved NAFLD. CONCLUSION: The study has demonstrated a mechanism by which the gut microbiome modulated oxidative stress in NAFLD mice induced by HFD. The traditional Chinese medicine TH improved NAFLD by regulating the gut microbiome, and its mechanism was related to the "-5-MIAA-Nrf2" pathway. It provided a promising way for the intervention of NAFLD.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9cc/9533869/9a9cb4d6dcf4/fmicb-13-984019-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9cc/9533869/a970faab4819/fmicb-13-984019-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9cc/9533869/5a4be3fce19d/fmicb-13-984019-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9cc/9533869/5c52ec55f68c/fmicb-13-984019-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9cc/9533869/9b90fb0a59b6/fmicb-13-984019-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9cc/9533869/a29bc56de963/fmicb-13-984019-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9cc/9533869/9a9cb4d6dcf4/fmicb-13-984019-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9cc/9533869/a970faab4819/fmicb-13-984019-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9cc/9533869/5a4be3fce19d/fmicb-13-984019-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9cc/9533869/5c52ec55f68c/fmicb-13-984019-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9cc/9533869/9b90fb0a59b6/fmicb-13-984019-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9cc/9533869/a29bc56de963/fmicb-13-984019-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9cc/9533869/9a9cb4d6dcf4/fmicb-13-984019-g006.jpg

相似文献

[1]
Tianhuang formula reduces the oxidative stress response of NAFLD by regulating the gut microbiome in mice.

Front Microbiol. 2022-9-21

[2]
Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.

mBio. 2021-8-31

[3]
Dingxin Recipe IV attenuates atherosclerosis by regulating lipid metabolism through LXR-α/SREBP1 pathway and modulating the gut microbiota in ApoE mice fed with HFD.

J Ethnopharmacol. 2021-2-10

[4]
Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.

J Ethnopharmacol. 2022-8-10

[5]
Effect of Sheng-Jiang Powder on Gut Microbiota in High-Fat Diet-Induced NAFLD.

Evid Based Complement Alternat Med. 2020-11-26

[6]
Multi-omics joint analysis reveals that the Miao medicine Yindanxinnaotong formula attenuates non-alcoholic fatty liver disease.

Phytomedicine. 2024-12

[7]
Yinchen Linggui Zhugan decoction ameliorates high fat diet-induced nonalcoholic fatty liver disease by modulation of SIRT1/Nrf2 signaling pathway and gut microbiota.

Front Microbiol. 2022-12-12

[8]
Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice.

Drug Des Devel Ther. 2020

[9]
Deciphering the mechanism of jujube vinegar on hyperlipoidemia through gut microbiome based on 16S rRNA, BugBase analysis, and the stamp analysis of KEEG.

Front Nutr. 2023-5-19

[10]
Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NFB Signaling Pathway and Restores Gut Microbiota in High-Fat-Diet-Fed Mice.

Oxid Med Cell Longev. 2020-11-3

引用本文的文献

[1]
Serum metabolic and microbial profiling yields insights into promoting effect of tryptophan-related metabolites for health longevity in centenarians.

Imeta. 2025-4-20

[2]
A Scoping Review on Hepatoprotective Mechanism of Herbal Preparations through Gut Microbiota Modulation.

Curr Issues Mol Biol. 2024-10-16

[3]
Chinese herbal formula in the treatment of metabolic dysfunction-associated steatotic liver disease: current evidence and practice.

Front Med (Lausanne). 2024-10-8

[4]
The Role of Antioxidants in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review.

Antioxidants (Basel). 2024-6-29

[5]
Assessment of metabolomic variations among individuals returning to plain areas after exposure to high altitudes: a metabolomic analysis of human plasma samples with high-altitude de-acclimatization syndrome.

Front Mol Biosci. 2024-6-19

[6]
Decoding the role of immune T cells: A new territory for improvement of metabolic-associated fatty liver disease.

Imeta. 2023-1-18

[7]
The Hepatoprotective Effects of Ginsenoside from Ginseng: A Review of Molecular Mechanisms and Therapeutic Potentials.

Curr Pharm Biotechnol. 2025

[8]
Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies.

Chin Med. 2024-2-3

[9]
The dysfunction in intestinal microorganisms and enzyme activity as significant contributors to diarrhea with kidney-yang deficiency syndrome.

Front Microbiol. 2024-1-9

[10]
Exploring global research status and trends in anti-obesity effects of traditional Chinese medicine through intestinal microbiota: a bibliometric study.

Front Cell Infect Microbiol. 2023

本文引用的文献

[1]
Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice.

J Inflamm Res. 2021-5-17

[2]
Geniposide and Chlorogenic Acid Combination Improves Non-Alcoholic Fatty Liver Disease Involving the Potent Suppression of Elevated Hepatic SCD-1.

Front Pharmacol. 2021-5-4

[3]
Tian-Huang Formula, a Traditional Chinese Medicinal Prescription, Improves Hepatosteatosis and Glucose Intolerance Targeting AKT-SREBP Nexus in Diet-Induced Obese Rats.

Evid Based Complement Alternat Med. 2021-3-6

[4]
Hepatoprotective Effects of Indole, a Gut Microbial Metabolite, in Leptin-Deficient Obese Mice.

J Nutr. 2021-6-1

[5]
Gut-liver axis modulation of Panax notoginseng saponins in nonalcoholic fatty liver disease.

Hepatol Int. 2021-4

[6]
Treatments for NAFLD: State of Art.

Int J Mol Sci. 2021-2-26

[7]
Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease.

Eur J Pharmacol. 2021-5-5

[8]
Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase.

Redox Biol. 2021-5

[9]
combined with fiber amplifies metabolic and immune benefits in obese mice.

Gut Microbes. 2021

[10]
Probiotic Lactobacillus casei Shirota prevents acute liver injury by reshaping the gut microbiota to alleviate excessive inflammation and metabolic disorders.

Microb Biotechnol. 2022-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索